100% Quality Guarantee
PhD-Level Technical Support
Key Features

Human CDA (Cytidine Deaminase) ELISA Kit (AEKE08639)

SKU AEKE08639
Reactivity Human
Detection Method Sandwich
Sensitivity 0.31 ng/mL
Standard 50 ng/mL
Range 0.79-50 ng/mL
$857 - $7,710

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

Human CDA ELISA Kit

Human CDA ELISA kits are used to detect Cytidine Deaminase (CDA) in serum, plasma, tissue homogenates and other biological samples. CDA, cytidine deaminase, is a zinc-dependent enzyme of the pyrimidine salvage pathway that scavenges exogenous and endogenous cytidine and 2'-deoxycytidine, converting them by hydrolytic deamination to uridine and deoxyuridine, so that they can be used for UMP synthesis. It is expressed in the liver, spleen, granulocytes and other tissues. CDA also deaminates nucleoside analogue drugs such as cytarabine, gemcitabine and decitabine, inactivating them, so its activity strongly influences their efficacy and toxicity. Common variants in the CDA gene that alter enzyme activity have been associated with adverse reactions to gemcitabine and cytarabine, and CDA activity levels have been examined as a pharmacogenetic marker. CDA is therefore a focus of research in nucleotide metabolism and chemotherapy response.

system_update_altDatasheetsystem_update_altMSDS
View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose